Update from IMS on Novel Technologies in Multiple Myeloma | Gareth Morgan, MD, PhD | IMS 2023

Update from IMS on Novel Technologies in Multiple Myeloma | Gareth Morgan, MD, PhD | IMS 2023
Monoclonal Gammopathy of Unknown Significance | Urvi Shah, MD | IMS 2023
Using a Single Cell Approach to Define Mechanisms of Progression | Irene Ghobrial, MD | IMS 2023
Serial MRD Assessments as a Surrogate for Long Term PFS | Frits van Rhee, MD | IMS 2023
Sustained MRD Negativity in Transplant Eligible Patients | Camila Guerrero, PhD | IMS 2023
HealthTree Foundation Pillar Three: A Powerful Patient Data Portal
